SEC Form 4 · accession 0001144204-18-034459
Checkpoint Therapeutics, Inc. · CKPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Boilen
Director
Period of report
Jun 14, 2018
Accepted (ET)
Jun 15, 2018 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651407
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1,F2 | Jun 14, 2018 | A | 16,448 | $0.00 | A | 98,670 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Mr. Boilen's continued service on the board on such date.
- F2Includes 76,448 shares of restricted Common Stock which vest over various time periods.